Tirzepatide, available as injection (at $289/mo month-to-month, or from $249/mo on the 6-month plan) or oral (at $349/mo month-to-month, or from $279/mo on the 6-month plan), targets both GLP-1 and GIP receptors and may produce greater weight loss and cholesterol improvements than semaglutide alone
A typical physician-directed protocol runs: weeks 1-4 at 1-2% concentration (introductory), weeks 4-12 at 2-5% (standard therapeutic), months 3+ at optimized concentration for ongoing maintenance
The BJP and its coalition partners will form a government that is a strong supporter of science in a broad sense, researchers say
The long-term weight management picture has one part that doesn't make it into most ads: stopping GLP-1 therapy is consistently associated with weight regain in clinical extension studies
equity market will grind higher for the rest of the year with intermittent bouts of volatility
Youre at heightened risk for accidents , falls, and dangerous driving incidents